Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum Concordia Healthcare Corp. T.CXR.R

TSX:CXR.R - Post Discussion

Concordia Healthcare Corp. > Yesterday's Committee Meeting...
View:
Post by happyretirement on Jan 24, 2017 9:51am

Yesterday's Committee Meeting...

Have not received a transcript, but here is the actual meeting video...long winded at times, but if you are interested in the attempt to create a bill that would satisfy everyone involved from the NHS, patients and the actual pharmaceutical industry the first few minutes give issues that Lords having concern may not be answered with this bill.

Contains Parliamentary information licensed under the Open Parliament Licence v3.0.

https://www.parliamentlive.tv/Event/Index/8625b46b-b33b-47c5-8b26-d829777ce51d
Comment by Health123 on Jan 24, 2017 10:14am
Billy Kenber, the hotshot investigative journalist that exposed the AMCo pricing scandal, has the link of the transcripts on his twitter account.  As well, anyone can sign up on the UK site to receive the transcripts via email.   Looks like the bill will be made law within a couple of months (RBC says by spring) and AMCo's days of price gouging will be over.
Comment by Health123 on Jan 24, 2017 10:15am
Oh and I just see Cohodes @AlderLaneeggs retweeted the Billy Kenber's post with the link!
Comment by meetoo1600 on Jan 24, 2017 11:23am
Health123, the days of AMCos price gouging will not end with the passage of this legislation. In fact, they ended a long time ago. Price gouging is no longer any part of Concordia's strategy in the UK or elsewhere. It has not been for awhile. This is not only because of the CMA investigation and this pending legislation. Competition has not and does not allow it. The big gamble with this ...more  
Comment by Health123 on Jan 24, 2017 10:28pm
You clearly do not understand the AMCo portfolio.  80% of their products have less than two competitors.  And you making a statement that they have stopped price increases and can you verify your comments with reference to their 10 top selling molecules and the recent nhs tariff book? Nah, didn't think so...  but good luck making stuff up.
Comment by meetoo1600 on Jan 25, 2017 10:47am
Why are you so angry at everyone? If people want to risk their money on what you believe is a bad investment, why not just let them, and go and get a real life for yourself.  Find someone to love.  Maybe he or she will love you back.
Comment by meetoo1600 on Jan 25, 2017 10:48am
I am was replying to Health123.
Comment by Health123 on Jan 25, 2017 10:59am
I'm not angry at all..  That is like me saying that you must be a depressed, pathetic person because you seem to always be whining about shorts posting here.  First and foremost, I enjoy it.  Knowing that it will be read, and perhaps need to be defended, helps me.  If I missed something or am wrong, I want to hear about it and fast as there are several intelligent people ...more  
Comment by happyretirement on Jan 24, 2017 10:24am
Contains Parliamentary information licensed under the Open Parliament Licence v3.0. https://hansard.parliament.uk/lords/2017-01-23/debates/7F5F994C-3451-4202-9D28-905A1D5C1C97/HealthServiceMedicalSupplies(Costs)Bill
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities